関連する実験動画
Updated: Aug 17, 2026

07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
コンのアデノーマによる一次性アルドステロン症における左心房の改造
G P Rossi1, A Sacchetto, E Pavan
1Department of Clinical and Experimental Medicine, University of Padua Medical School, Italy. gprossi@ipdunidx.unipd.it
Circulation
|March 18, 1997
まとめ
アルドステロン産生性腺腫 (APA) のアルドステロンの過剰摂取は,エッセンシャル高血圧と比較して,心臓の壁が厚くなり,静脈充填が損なわれる. これは,アルドステロンの心臓の構造と機能に対する直接的な影響を強調しています.
科学分野:
- 心臓病学 心臓病学
- エンドクリノロジー エンドクリノロジー
- 高血圧の研究 高血圧の研究
背景:
- ハイパーアルドステロン症は,実験的に心筋のインタースティシャル線維症と関連付けられています.
- アルドステロン産生性腺腫 (APA) はアルドステロンの過剰と高血圧を引き起こす.
研究 の 目的:
- APA患者における高血圧と過剰アルドステロンの心臓効果を調査する.
- APA患者における心臓の構造と機能を,エッセンシャル高血圧 (EH) 患者と比較するために.
主な方法:
- ドップラーエコーカルディオグラフィは,左心室 (LV) の寸法と充填を評価するために使用されます.
- 24時間循環式血圧モニタリング.
- 26人のAPA患者と26人のEH患者のマッチング比較.
主要な成果:
- APA患者には,EH患者よりも腹腔間隔膜と後部壁が厚く,LV質量指数が高かった.
- LV壁の厚さは,年齢,血アルドステロン,平均血圧と相関しています.
- APA患者では,初期静脈静脈充填の減少 (EiとEi/Ai比) と,静脈静脈充填に対する心房の寄与の増加を示した.
結論:
- APA患者におけるアルドステロンの過剰は,LV壁の厚さと質量の増加と関連しています.
- APA患者は,マッチングされたEH患者と比較して,早期のダイアストリックLV埋着の障害を示した.
- これらの心臓の変化は,同様の血圧プロファイルと変動性とは無関係に起こる.
関連する概念動画
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

